Abstract
Rats selected by predisposition to catalepsy showed decreased level of 2A-serotonin receptor mRNA in the frontal cortex in comparison with Wistar rats (p<0.05). Chronic administration of tricyclic antidepressant imipramine hydrochloride 2-fold increased the content of receptor mRNA in genetically cataleptic rats (p<0.001) and did not change this parameter in Wistar rats. These results prompted us to revise current notion on the mechanisms of chronic effect of imipramine on 2A-serotonin receptors.
Similar content being viewed by others
REFERENCES
N. N. Barykina, I. L. Chepkasov, T. A. Alekhina, and V. G. Kolpakov, Genetika, 12, 2014–2021 (1983).
A. V. Kulikov, A. V. Maksyutova, E. A. Ivanova, et al., Dokl. RAN, 383, 417–419 (2002).
E. L. Barker and R. D. Blakey, Psychopharmacology. The Fourth Generation of Progress, N. Y. (1985), pp. 321–333.
P. Blier and C. de Montigny, Trends Pharmacol. Sci., 15, 220–226 (1994).
F. Borsini, Pharmacol. Res., 30, 1–11 (1994).
P. W. Burnet, D. Michelson, M. A. Smith, et al., Brain Res., 638, 311–324 (1994).
P. Chomczynski and N. Sacchi, Anal. Biochem., 162, 156–159 (1987).
V. Klimek, J. Zak-Knapik, and M. Mackowiak, J. Psychiatry Neurosci., 19, 63–67 (1994).
E. M. Nikulina, N. K. Popova, V. G. Kolpakov, and T. A. Alekhina, Biogenic Amines, 4, 399–406 (1987).
G. Pineyro and P. Blier, Pharmacol. Rev., 51, 533–591 (1999).
N. K. Popova and A. V. Kulikov, Am. J. Med. Genet., 60, 214–220 (1995).
G. Spurlock, P. Buckland, M. O'Donovan, and P. McGuffin, Neuropharmacology, 33, 433–440 (1994).
M. N. Subhash and S. Jagadeesh, Neurochem. Res., 22, 1095–1099.
P. Willner, Pharmacol. Ther., 45, 425–455 (1990).
P. L. Zamorano, V. B. Mahesh, and D. W. Brann, Neuroendocrinology, 63, 397–407 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kulikov, A.V., Tikhonova, M.A., Barykina, N.N. et al. Effect of Chronic Administration of Imipramine on 2A-Serotonin Receptor mRNA in Brain Cortex of Rats Predisposed and Resistant to Catalepsy. Bulletin of Experimental Biology and Medicine 134, 168–170 (2002). https://doi.org/10.1023/A:1021144500515
Issue Date:
DOI: https://doi.org/10.1023/A:1021144500515